By Sheri Colberg, PhD Before the advent of blood glucose meters, discovering how much of an effect female hormones have on insulin action was impossible. If you’re female, past puberty, and still young enough to be menstruating, then you’ll want to find out more about factoring your time of …
Read More »Bite Counter = A Pedometer for Your Mouth
Bite Counter = A Pedometer for Your Mouth Count bites by tracking your wrist movement. Researchers have developed a way to fight obesity by helping people answer one fundamental question: how many bites of food are you eating? The Bite Counter, a wristwatch-shaped device being marketed to weight-loss clinics and fitness …
Read More »Scientists Getting Closer to a Possible Cure for Diabetes
Glucose-sensing enzyme holds the key to insulin production, according to breakthrough Israeli research pointing the way towards a possible cure for diabetes. Watch for a special Diabetes In Control interview with Dr. Dor coming soon….
Read More »EASD: Thorough Chewing Raises Hormones Regulating Food Intake
Thorough chewing stimulates the release of 2 intestinal peptides that reduce appetite and food intake in obese individuals, according to the results of a study.…
Read More »EASD: Intensified Treatment with Basal Insulin Improves Control and Weight Loss
Adding insulin detemir to a treatment regimen of metformin and liraglutide improved glycemic control and led to sustained weight loss for up to 52 weeks in patients with type 2 diabetes.…
Read More »EASD: Outpatient Test Discriminates MODY from Type 1 Diabetes
A measure of the postprandial ratio of urinary C-peptide to creatinine (UCPCR) can distinguish maturity-onset diabetes of the young (MODY) from type 1 diabetes mellitus, allowing some children who would otherwise be treated with insulin to receive oral antidiabetic agents alone….
Read More »EASD: ‘Gliptin’s’ May Be Heart Savers
While searching for potential cardiovascular risks among studies involving dipeptidyl peptidase-4 (DPP-4) inhibitors in type 2 diabetes patients, researchers made a surprising discovery –- treatment with the so-called gliptin class appears to protect the heart.…
Read More »New First in Class Glucagon Antagonists Show Promise for Diabetes
New data on two investigational glucagon receptor antagonists suggest that this novel class of drugs has potential to be an effective treatment for type 2 diabetes.…
Read More »EASD: Elevated Glucose Appears Years before Diabetes Diagnosis
In patients diagnosed with type 2 diabetes, elevations in blood levels of glucose and glycated hemoglobin (HbA1c) can be seen as much as 10 years prior to diagnosis.…
Read More »EASD: Positive Results for Two SGLT2 Inhibitors
The investigational drug ipragliflozin improved glycemic control and decreased body weight and blood pressure, according to the phase III BRIGHTEN study.…
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.